Papers/PMID:32544011
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology2021The record
3 findings drawn from this paper, on 1 compound across 3 endpoints.
What it reported
How to read these marksWhat moved
3 findings
coenzyme Q10 — decreases tumour necrosis factor alpha concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×1“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011
coenzyme Q10 — decreases C-reactive protein concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×2“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011
coenzyme Q10 — decreases interleukin-6 concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×1“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011